Clinical Trials Logo

Adult Growth Hormone Deficiency clinical trials

View clinical trials related to Adult Growth Hormone Deficiency.

Filter by:

NCT ID: NCT01706783 Completed - Clinical trials for Adult Growth Hormone Deficiency

A Trial Investigating the Safety, Tolerability, Availability and Distribution in the Body of Once-weekly Long-acting Growth Hormone (Somapacitan) Compared to Once Daily Norditropin NordiFlex® in Adults With Growth Hormone Deficiency

Start date: October 12, 2012
Phase: Phase 1
Study type: Interventional

This trial is conducted in Europe. The aim of the trial is to investigate the safety, tolerability, availability and distribution in the body of once-weekly long-acting growth hormone (NNC0195-0092, somapacitan) compared to once daily Norditropin NordiFlex® in adults with growth hormone deficiency (GHD).

NCT ID: NCT01580605 Completed - Clinical trials for Adult Growth Hormone Deficiency

French National Registry of Adults With Growth Hormone Deficiency Treated With Somatropin

Start date: July 17, 2003
Phase:
Study type: Observational

This study is conducted in Europe. The aim of this study is to extract data from the French National Registry holding information about patients having initiated growth hormone therapy with the objective to describe patients receiving growth hormone therapy, assess efficacy and safety of somatropin (Norditropin® SimpleXx®) and evaluate treatment compliance.

NCT ID: NCT01562834 Completed - Clinical trials for Adult Growth Hormone Deficiency

Effect of Somatropin on Left Ventricular Mass in Growth Hormone Deficient Adult Patients

Start date: October 21, 1998
Phase: Phase 4
Study type: Interventional

This trial is conducted in Europe. The aim of this trial is to assess the effect of somatropin (Norditropin®) replacement therapy on the left ventricular mass of adult patients with a growth hormone deficiency.

NCT ID: NCT01543880 Completed - Clinical trials for Adult Growth Hormone Deficiency

Safety and Efficacy of Long-term Somatropin Treatment in Adults

NordiWIN
Start date: July 2003
Phase: N/A
Study type: Observational

This study is conducted in Europe. The aim of the study is to evaluate safety and efficacy in adults treated with somatropin (Norditropin®).

NCT ID: NCT01514500 Completed - Healthy Clinical Trials

First Human Dose Trial of NNC0195-0092 (Somapacitan) in Healthy Subjects

Start date: January 16, 2012
Phase: Phase 1
Study type: Interventional

This trial is conducted in Europe. The aim of this trial is to assess safety, tolerability, pharmacokinetics (the exposure of the trial drug in the body) and pharmacodynamics (the effect of the investigated drug on the body) of NNC0195-0092 (somapacitan) compared to placebo in healthy male subjects.

NCT ID: NCT01282164 Completed - Clinical trials for Adult Growth Hormone Deficiency

The Glucagon Stimulation Test for Evaluation of Adult Growth Hormone Deficiency and Adrenocorticotropic Axis

GST
Start date: January 2011
Phase: N/A
Study type: Interventional

The purpose of this study is to find out if the Glucagon Stimulation Test (GST) is a reliable alternative to the Insulin Tolerance Test (ITT) for diagnosis of Growth Hormone Deficiency (GHD) and adrenal insufficiency. In some patients the accuracy of the GST for evaluation of adrenal insufficiency is compared to the adrenocorticotropin hormone (ACTH ) stimulation test.

NCT ID: NCT01225666 Completed - Clinical trials for Adult Growth Hormone Deficiency

MOD-4023 (Long-Lasting Human Growth Hormone (hGH)) Study in Growth Hormone Deficient Adults (GHDA)

Start date: August 2010
Phase: Phase 2
Study type: Interventional

This study aims to assess the safety, tolerability and Pharmacokinetics/ Pharmacodynamics (PK/PD) profile of three doses of MOD-4023 on a weekly regime and one dose on an every-other-week regime administered for a period of 4 weeks in Growth Hormone Deficient Adult (GHDA) patients who previously were on a stable r-hGH treatment. An additional extension period of 16 weeks once-weekly administration of MOD-4023 aims to confirm the dose selection for future trials.

NCT ID: NCT01109017 Completed - Clinical trials for Adult Growth Hormone Deficiency

Observational Study of the Safety and Efficacy of Norditropin® in Adult Patients With Growth Hormone Deficiency

Start date: October 2009
Phase: N/A
Study type: Observational

This study is conducted in Japan. The aim of this observational study is to collect information about the safety and efficacy of Norditropin® long-term treatment of growth hormone deficiency in adults.

NCT ID: NCT01080755 Completed - Clinical trials for Adult Growth Hormone Deficiency

Metabolic Endocrinology and Growth Hormone in Adults

MEGHA FRANCE
Start date: December 2003
Phase: N/A
Study type: Observational

This is a multicentric, longitudinal, observational study with the prospective follow-up of Adult subjects with Growth Hormone Deficiency (AGHD) being treated with Saizen, every six months in the first year and then annually. At the request of health authorities, the sponsor has arranged for the follow-up of prescriptions and treated subjects within the scope of this indication.

NCT ID: NCT00960128 Completed - Clinical trials for Chronic Kidney Disease

Observational Prospective Study on Patients Treated With Norditropin®

Start date: April 1, 2006
Phase: N/A
Study type: Observational

This observational study is conducted globally. The aim of the study is to investigate the effectiveness and safety of real-life treatment with Norditropin®. The study population will consist of children and adults who are on treatment with Norditropin® in accordance with normal clinical practice.